BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Clinical trial NCT01389323 · COMPLETED
Trial details
- NCT number
- NCT01389323
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-09-01
- Enrollment
- 448
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.